Classical and Speech Therapy Olfactory Training in the Treatment of COVID-19-Related Olfactory Disorders.

Publication date: Sep 08, 2026

BACKGROUND Loss of smell can impair quality of life. Olfactory disorders are often caused by viral infections, including SARS-CoV-2. The aim of the study was to evaluate the effectiveness of a structured, multidisciplinary rehabilitation program, including pharmacological treatment and speech therapy-guided olfactory training, in patients with post-COVID olfactory disorders. MATERIAL AND METHODS A total of 75 patients (15 men, 60 women) were allocated to a study group (n=50) or control group (n=25) using a systematic assignment method. Both groups received the same pharmacological treatment (intranasal corticosteroids and topical vitamin A), saline nasal irrigation, and elements of speech therapy-guided olfactory training. In addition, the study group performed classical olfactory training using 4 odorants twice daily. Olfactory function was assessed using the Sniffin’ Sticks Test (SST). RESULTS For the total SST score, the mean change before and after intervention in the study group was 7. 9 points (P

Concepts Keywords
Classical Adrenal Cortex Hormones
Daily Adrenal Cortex Hormones
Pharmacological Adult
Viral Aged
Women COVID-19
Female
Humans
Male
Middle Aged
Olfaction Disorders
Olfactory Training
Post-Acute COVID-19 Syndrome
SARS-CoV-2
Smell
Speech Therapy
Treatment Outcome
Vitamin A
Vitamin A

Semantics

Type Source Name
disease MESH COVID-19
disease MESH Loss of smell
disease MESH viral infections
drug DRUGBANK Vitamin A
disease MESH Olfaction Disorders
disease MESH Post-Acute COVID-19 Syndrome

Original Article

(Visited 4 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *